Business
COVID-19 vaccine from China’s Sinovac 91.25 per cent effective, Turkey says after trial involving 7,000 volunteers – ABC News
A COVID-19 vaccine developed by China’s Sinovac Biotech is 91.25 per cent effective, according to interim data from a late-stage trial in Turkey.
A COVID-19 vaccine developed by China’s Sinovac Biotech has been 91.25 per cent effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil.
Key points:
- The Turkish trials began on September 14 and have included more than 7,000 volunteers
- Common adverse effects caused by the vaccine were fever, mild pain and slight fatigue
- 26 of the 29 people who were infected during the trial were given placebos
…
Continue Reading
-
General22 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General16 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News20 hours agoMeticulously crafted home in heart of Noosa Heads
-
General19 hours ago‘Mother’s Day’ solar storm squeezed Earth’s plasmasphere to one-fifth its size